INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Gut Microbiome / Health Desk

Low FODMAP in IBS: what a provided-food crossover can establish

A short controlled trial separated symptom relief from changes in stool measurements.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

A comparison with unusually tight food control

The trial enrolled 30 people with irritable bowel syndrome and eight healthy controls matched for demographics and diet. After recording one habitual week, participants received either a low-FODMAP diet or a typical Australian diet for 21 days. They later crossed to the other diet after a washout of at least 21 days. Almost all food was provided during the intervention periods. That detail matters when interpreting the result: this was a comparison of controlled dietary packages, not simply a leaflet asking people to avoid a few foods. It does not establish how closely the same contrast would be reproduced in ordinary shopping and cooking.

Halmos EP, Power VA, Shepherd SJ, Gibson PR et al.. Gastroenterology, 2014. PMID 24076059 · DOI

The symptom scale, not a cure rate

Among participants with IBS, overall gastrointestinal symptom scores averaged 22.8 mm during the low-FODMAP period, compared with 44.9 mm during the Australian-diet period. The scale ran from zero to 100 mm, and the between-diet comparison had a P value below .001. The reported confidence intervals were 16.7–28.8 mm and 36.6–53.1 mm, respectively. These are symptom-score results rather than percentages cured. Bloating, pain, and passage of wind also decreased on the low-FODMAP diet. The abstract therefore supports short-term symptom relief under the study conditions, without establishing permanent resolution or a long-term dietary endpoint.

Halmos EP, Power VA, Shepherd SJ, Gibson PR et al.. Gastroenterology, 2014. PMID 24076059 · DOI

Stool satisfaction and measured stool outcomes differ

The researchers collected all stools during days 17–21 and assessed frequency, weight, water content, and stool-chart ratings. Participants across IBS subtypes reported greater satisfaction with stool consistency on the low-FODMAP diet. However, diarrhea-predominant IBS was the only subtype in which fecal frequency and King's Stool Chart scores changed. Those findings should not be collapsed into a claim that every stool measurement improved in every participant. Subjective satisfaction and measured bowel characteristics answer related but different questions. The abstract reports a broader improvement in satisfaction than in the specified subtype-dependent stool measurements, an important qualification to the symptom headline.

Halmos EP, Power VA, Shepherd SJ, Gibson PR et al.. Gastroenterology, 2014. PMID 24076059 · DOI

Where the finding stops

Healthy controls had minimal symptoms that were not altered by either diet. That result places the main symptom finding in the IBS population actually studied, rather than suggesting a general benefit for everyone. The controlled intervention periods lasted 21 days each and involved nearly complete food provision. Neither feature establishes a sustainable long-term menu or identifies which individual ingredient produced the difference. For a plant-based reader, this is evidence about a specific dietary comparison, not evidence against all foods containing fermentable carbohydrates. The trial abstract also does not test any recipe paired with this article as an IBS intervention.

Halmos EP, Power VA, Shepherd SJ, Gibson PR et al.. Gastroenterology, 2014. PMID 24076059 · DOI